Celecor Therapeutics

Developer of POC subcutaneous injectable for treating myocardial infarction

placeSan Diego, California, United States calendar_todayFounded 2017 groups7 employees language celecor.com

Social engagement

Social engagement: 1.3K social following, 9 posts in the last 12 months — top 10% of its industry.

Investor mix

1 investor on record.

Investor typeCountShare
Accelerator & incubator1100%

Recent activity

29 Mar 2026
Event
American College of Cardiology annual meeting
28 Mar 2026
Event
American College of Cardiology annual mtg
23 Feb 2026
Event
Neutral Therapeutics in MI and ACS Management session
Coming soon